Clinical Trial

Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to analyze the usability and safety of the robotic gait ATLAS 2030 in a cohort of pediatric patients with Spinal Cord Injury, with the aim of extending its indication for use to pediatric spinal cord injury
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-08; most recent amendment 2025-08-11.
Status change: Not Yet Recruiting → Recruiting 2025-02-26
Trial Details
NCT Number NCT06772077
Lead Sponsor MarsiBionics
Collaborators: Hospital Nacional de Parapléjicos de Toledo, Fundación del Lesionado Medular
Conditions Spinal Cord Injury (SCI)
Enrollment 20 participants
Start Date 2025-02-17
Primary Completion 2026-02 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-14